Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

June 2027 167

  1. Primary completion Design and Rationale of the COLT Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07432529

  2. Primary completion SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07614230

  3. Primary completion Capitalizing on AI to CapTure Undiagnosed Structural Heart Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07843004

  4. Primary completion The Impact of Using Nicorandil for the Prevention of Doxorubicin-Induced Cardiotoxicity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07897409

  5. Primary completion Synbiotic as an Adjuvant Therapy for Dyslipidaemia and Gut Health Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07915687

  6. Study completion A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02098265

  7. Primary completion A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02098265

  8. Primary completion Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03242642

  9. Primary completion Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04634916

  10. Study completion Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04670666

  11. Primary completion Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04748796

  12. Primary completion Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05111288

  13. Study completion Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05589454

  14. Study completion COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05873881

  15. Primary completion COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05873881

  16. Primary completion To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05908084

  17. Primary completion SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06001827

  18. Primary completion Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06027307

  19. Primary completion Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06029491

  20. Primary completion Dapagliflozin in STEMI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06174753

  21. Primary completion Study of BB-031 in Acute Ischemic Stroke Patients (RAISE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06226805

  22. Primary completion REstoration of VItamin D in Pulmonary Arterial Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06258850

  23. Primary completion Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06317805

  24. Study completion Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06337838

  25. Study completion Adaptive Cognitive Training on Cognitive Function in Elderly Hypertension Patients in the Community Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06512922

  26. Study completion Adaptive Cognitive Training on Cognitive Function in Elderly Diabetes Patients in the Community Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06524388

  27. Primary completion ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™ Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06608823

  28. Primary completion The STTAR-US Study: A Pivotal Study of Transcatheter Tricuspid Annular Repair in the US Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06700239

  29. Study completion Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06712030

  30. Primary completion Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06784466

  31. Primary completion Landiolol in Mitral Valve Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06793670

  32. Study completion Towards a More Standardized Bicuspid Aortic Valve Repair: Rationale and Design of CONTOUR Trial - a Randomized Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06869954

  33. Primary completion Towards a More Standardized Bicuspid Aortic Valve Repair: Rationale and Design of CONTOUR Trial - a Randomized Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06869954

  34. Study completion Comparison of Single vs. Dual Perclose Devices for Large-Bore Access Closure in TAVR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06871774

  35. Primary completion Comparison of Single vs. Dual Perclose Devices for Large-Bore Access Closure in TAVR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06871774

  36. Study completion A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06897475

  37. Study completion Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06917664

  38. Study completion Evaluation of a Novel Intrasaccular Embolization Device for the Treatment of Intracranial Aneurysms Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07022249

  39. Primary completion Evaluation of a Novel Intrasaccular Embolization Device for the Treatment of Intracranial Aneurysms Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07022249

  40. Primary completion Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07091682

  41. Study completion A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07142356

  42. Primary completion AI-Assisted Interpretation of Cardiac CT in the Emergency Department Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07235657

  43. Study completion Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07241338

  44. Study completion The Digital Diabetes Patient Reminder (DIPAR) Tool For Adults With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07257822

  45. Primary completion The Digital Diabetes Patient Reminder (DIPAR) Tool For Adults With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07257822

  46. Study completion Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07267949

  47. Study completion Ablation With the PFA System With a Large-Area Focal Catheter for the Treatment of Persistent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07281521

  48. Primary completion BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary Artery Disease (CAD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07363161

  49. Study completion The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07381803

  50. Study completion Strategy for EArly Recognition of Cancer, COPD & Heart Failure in the Emergency Department Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07391280

  51. Primary completion Strategy for EArly Recognition of Cancer, COPD & Heart Failure in the Emergency Department Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07391280

  52. Primary completion Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07439133

  53. Study completion Neurophysiological Markers for Prediction of Rehabilitation Outcomes After Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07520630

  54. Primary completion Multi-Site STARgraft (10401) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07557862

  55. Primary completion Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07687706

  56. Primary completion Evaluating SGLT2 Inhibitors for the Reduction of No-Reflow Phenomenon in Patients Undergoing PCI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07898709

  57. Study completion Effectiveness and Tolerability of a Treat-to-Target Versus Fixed-Dose Statin Strategy in Patients With Atherosclerotic Cardiovascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07909915

  58. Primary completion Effectiveness and Tolerability of a Treat-to-Target Versus Fixed-Dose Statin Strategy in Patients With Atherosclerotic Cardiovascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07909915

  59. Primary completion Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap? Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07295522

  60. Primary completion Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07817251

  61. Study completion Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07263776

  62. Primary completion Implementing Food Referrals for Equity and Sustained Health Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06661538

  63. Primary completion Noninferiority Trial Of Sirolimus With Ascorbic Acid Versus Everolimus in All-comers Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07566091

  64. Primary completion Gastric Feeding for the Prevention of Stroke-Associated Pneumonia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07630090

  65. Primary completion Prevent Cardiac Surgery Associated AKI Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06620523

  66. Primary completion CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05422534

  67. Primary completion Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07263308

  68. Study completion Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03445949

  69. Primary completion GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06578741

  70. Study completion Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01385176

  71. Primary completion Coronary Atherosclerosis T1-Weighted Characterization (CATCH) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03504956

  72. Primary completion Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04014803

  73. Study completion NobleStitch EL STITCH Trial is a PFO Comparative Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04339699

  74. Study completion Firehawk Rapamycin Target Eluting Coronary Stent North American Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04562532

  75. Primary completion The Arteriovenous Vascular (AV) ACCESS Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04646226

  76. Study completion Sonification Techniques for Gait Training Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04876339

  77. Study completion The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05034432

  78. Primary completion Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05283356

  79. Study completion Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05337241

  80. Primary completion Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05337241

  81. Study completion GENOSS Coronary Stent Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05444452

  82. Primary completion GENOSS Coronary Stent Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05444452

  83. Primary completion SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06054035

  84. Primary completion Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06092736

  85. Study completion Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06187311

  86. Study completion Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06250712

  87. Primary completion Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06250712

  88. Primary completion Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06284642

  89. Study completion Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06317805

  90. Study completion Evaluating the Impact of Home-Based Sleep Apnea Diagnostic on Well-Being, Health Behavior, and AF Load in Patients With Atrial Fibrillation Using a Decentralized Platform Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06618417

  91. Study completion Wide-Antral Pulmonary Vein Isolation in Atrial Fibrillation Ablation with a Single-shot Technique (WIDER-PVI) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06698159

  92. Study completion Intravenous Thrombolysis and NOAC Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06749834

  93. Primary completion Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06841965

  94. Primary completion Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06841978

  95. Primary completion Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06853535

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Primary completion Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI Registry record

    Expected 2018-12-31; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03045562

  2. Study completion Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients Registry record

    Expected 2018-12-31; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03047772

  3. Primary completion Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients Registry record

    Expected 2018-12-31; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03047772

  4. Study completion Study Comparing Pulmonary Vein Isolation With the Cryoballoon and Radiofrequency Energy(Contact Force) in the Treatment of Persistent Atrial Fibrillation (AF) (Cryo Vs CF in PerAF) Registry record

    Expected 2018-12-31; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03053570

  5. Primary completion Study Comparing Pulmonary Vein Isolation With the Cryoballoon and Radiofrequency Energy(Contact Force) in the Treatment of Persistent Atrial Fibrillation (AF) (Cryo Vs CF in PerAF) Registry record

    Expected 2018-12-31; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03053570

  6. Primary completion Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03072082

  7. Primary completion Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03072121

  8. Study completion Study on Vulnerable Plaque of Carotid Artery With Chinese Herbal and Insects Medicine Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03072225

  9. Study completion Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump Therapy Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03112538

  10. Primary completion Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump Therapy Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03112538

  11. Primary completion Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03121053

  12. Primary completion Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes Registry record

    Expected 2018-12; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03377335

  13. Study completion Effect of Hyperuricaemia on Chronic Renal Disease Registry record

    Expected 2018-12-31; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03425708

  14. Primary completion Effect of Hyperuricaemia on Chronic Renal Disease Registry record

    Expected 2018-12-31; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03425708

  15. Study completion the Effect of Calcium Dobesilate on Non Dialysis Patients With CKD Registry record

    Expected 2018-12-31; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03427944

  16. Primary completion the Effect of Calcium Dobesilate on Non Dialysis Patients With CKD Registry record

    Expected 2018-12-31; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03427944

  17. Study completion Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPRO Registry record

    Expected 2018-12-31; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03602742

  18. Primary completion Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPRO Registry record

    Expected 2018-12-31; that period ended on 2018-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03602742

  19. Primary completion COmprehensive Remote Ischemic Conditioning in Myocardial Infarction Registry record

    Expected 2019-01-30; that period ended on 2019-01-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03233919

  20. Study completion The Effects of Empagliflozin on Arterial Wall Characteristics Registry record

    Expected 2019-01-30; that period ended on 2019-01-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03639545

  21. Primary completion Study of the Guardian System on Motor Recovery and Impact on Length of Stay in Ischemic Stroke Patients Registry record

    Expected 2019-01-30; that period ended on 2019-01-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03673241

  22. Primary completion Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics Registry record

    Expected 2019-01; that period ended on 2019-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01001962

  23. Study completion EArly Discharge After Transradial Stenting of CoronarY Arteries in High-Risk Patients of Bleeding Registry record

    Expected 2019-01; that period ended on 2019-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01084993

  24. Study completion REmote iSchemic Conditioning in acUtE BRAin INfarction Study Registry record

    Expected 2019-01; that period ended on 2019-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02189928

  25. Primary completion REmote iSchemic Conditioning in acUtE BRAin INfarction Study Registry record

    Expected 2019-01; that period ended on 2019-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02189928

  26. Study completion REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions Registry record

    Expected 2019-01; that period ended on 2019-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02580955

  27. Primary completion REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions Registry record

    Expected 2019-01; that period ended on 2019-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02580955

  28. Study completion Rule Out Transcatheter Aortic Valve Thrombosis With Post Implantation Computed Tomography (RETORIC) Registry record

    Expected 2019-01; that period ended on 2019-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02826200

  29. Study completion SAFE (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) Study Registry record

    Expected 2019-01; that period ended on 2019-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02959606

  30. Primary completion SAFE (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) Study Registry record

    Expected 2019-01; that period ended on 2019-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02959606

  31. Study completion Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement Registry record

    Expected 2019-01; that period ended on 2019-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03121053

  32. Study completion Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes Registry record

    Expected 2019-01; that period ended on 2019-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03377335

  33. Primary completion Optimizing Patient Usability Experience for Chronic Care Registry record

    Expected 2019-01; that period ended on 2019-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03628963

  34. Study start Trial for MicroPort's Firesorb BVS: FUTURE-III Registry record

    Expected 2019-01; that period ended on 2019-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03660202

  35. Study start Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and Anxiety Registry record

    Expected 2019-02-01; that period ended on 2019-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03667677

  36. Study start CUHK Jockey Club HOPE 4 Care Programme - Ankle Robot Registry record

    Expected 2019-02-01; that period ended on 2019-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03808428

  37. Study start Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System Registry record

    Expected 2019-02-23; that period ended on 2019-02-23.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03788590

  38. Study completion Optimised Pacing Program Registry record

    Expected 2019-02-28; that period ended on 2019-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01819662

  39. Study completion External Compression Therapy for Secondary Prevention of Lower-Limb Loss and Cardiovascular Mortality Registry record

    Expected 2019-02; that period ended on 2019-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02054416

  40. Study completion Once-a-day Tacrolimus Conversion Study: The OneTAC Trial Registry record

    Expected 2019-02; that period ended on 2019-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02545972

  41. Primary completion Reappraisal of GIK in Acute STEMI by Pre-hospital Administration Registry record

    Expected 2019-02; that period ended on 2019-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02591927

  42. Study completion Technology for Innovative Monitoring of Cardiovascular Prevention: a RCT Registry record

    Expected 2019-02; that period ended on 2019-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03005470

  43. Primary completion Technology for Innovative Monitoring of Cardiovascular Prevention: a RCT Registry record

    Expected 2019-02; that period ended on 2019-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03005470

  44. Study completion Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization Registry record

    Expected 2019-02; that period ended on 2019-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03072082

  45. Study completion Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization Registry record

    Expected 2019-02; that period ended on 2019-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03072121

  46. Study completion Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF) Registry record

    Expected 2019-02; that period ended on 2019-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03096613

  47. Primary completion Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF) Registry record

    Expected 2019-02; that period ended on 2019-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03096613

  48. Primary completion Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy Registry record

    Expected 2019-02-28; that period ended on 2019-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03262363

  49. Study completion DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris Registry record

    Expected 2019-02; that period ended on 2019-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03633890

  50. Primary completion DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris Registry record

    Expected 2019-02; that period ended on 2019-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03633890

  51. Study start Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction Registry record

    Expected 2019-03-01; that period ended on 2019-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03658031

  52. Primary completion Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population Registry record

    Expected 2019-03-01; that period ended on 2019-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03696940

  53. Study start Dose Effect of Tranexamic Acid on the Incidence of Deep Venous Thrombus in Cardiac Surgery Registry record

    Expected 2019-03-01; that period ended on 2019-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03838328

  54. Study start AUSTrian Randomized Interventional Study on Dialysis Accesses Registry record

    Expected 2019-03-06; that period ended on 2019-03-06.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03764358

  55. Primary completion Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement Registry record

    Expected 2019-03-15; that period ended on 2019-03-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03440268

  56. Primary completion CPAP for OSA on Myocardial Salvage After pPCI for STEMI Patients Registry record

    Expected 2019-03-24; that period ended on 2019-03-24.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03444857

  57. Study completion Study of the Guardian System on Motor Recovery and Impact on Length of Stay in Ischemic Stroke Patients Registry record

    Expected 2019-03-28; that period ended on 2019-03-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03673241

  58. Primary completion Tecarfarin Anti-Coagulation Trial (TACT) Registry record

    Expected 2019-03-30; that period ended on 2019-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02522221

  59. Primary completion H-Type Hypertension Precision Medicine Trial Registry record

    Expected 2019-03-30; that period ended on 2019-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03472508

  60. Primary completion Consequences of Obstructive Sleep Apnea Syndrome (OSAS) After Ischemic Subtentorial Stroke. Registry record

    Expected 2019-03; that period ended on 2019-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01561677

  61. Primary completion Bedside Genetic or Pharmacodynamic Testing to Prevent Periprocedural Myonecrosis During PCI (ONSIDE TEST) Registry record

    Expected 2019-03; that period ended on 2019-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01930773

  62. Study completion A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction Registry record

    Expected 2019-03; that period ended on 2019-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01942070

  63. Study start Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI Registry record

    Expected 2019-03; that period ended on 2019-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02323620

  64. Primary completion Optimized Management of Comorbidity in Heart Failure With Preserved Ejection Fraction in the Elderly (>60 Years) Registry record

    Expected 2019-03; that period ended on 2019-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02425371

  65. Primary completion Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation Registry record

    Expected 2019-03; that period ended on 2019-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02502110

  66. Study completion Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents Registry record

    Expected 2019-03; that period ended on 2019-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02508714

  67. Study completion Critical Limb Ischemia Rapid Delivery by SurgWerks-CLI Kit and VXP System Registry record

    Expected 2019-03; that period ended on 2019-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02538978

  68. Study completion Spironolactone in Atrial Fibrillation Registry record

    Expected 2019-03; that period ended on 2019-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02673463

  69. Primary completion Once-daily Fixed Combination of Three Antihypertensive Drugs Registry record

    Expected 2019-03; that period ended on 2019-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02710539

  70. Primary completion Low-dose Combination of Three Antihypertensive Drugs Registry record

    Expected 2019-03; that period ended on 2019-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02710552

  71. Study completion A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy Registry record

    Expected 2019-03-31; that period ended on 2019-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02920593

  72. Primary completion Repetitive Levosimendan Infusion for Patients With Advanced Chronic Heart Failure Registry record

    Expected 2019-04-01; that period ended on 2019-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03437226

  73. Study start Prevention of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT Ⅱ) Registry record

    Expected 2019-04-01; that period ended on 2019-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03786757

  74. Study start A Randomized, Two-arm, Open Label Study to evalUate the Effect of a Smart Phone-based Patient Support Tool On Patient AdheRence of Treatment in Stable Angina Patients Prescribed Beta-blockers in China (SUPPORT) Registry record

    Expected 2019-04-01; that period ended on 2019-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03794713

  75. Study start CUHK Jockey Club HOPE 4 Care Programme - FES Bike Registry record

    Expected 2019-04-01; that period ended on 2019-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03848624

  76. Study start Registry to Evaluate Chinese Real-World Clinical Outcomes in Patients With AF Using the WATCHMAN Left Atrial Appendage Closure Technology Registry record

    Expected 2019-04-20; that period ended on 2019-04-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03917563

  77. Primary completion Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus Registry record

    Expected 2019-04; that period ended on 2019-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02162550

  78. Primary completion Optimized Remote Ischemic Conditioning (RIC) Treatment for Patients With Chronic Cerebral Ischemia Registry record

    Expected 2019-04; that period ended on 2019-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03105141

  79. Primary completion Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD Registry record

    Expected 2019-04-30; that period ended on 2019-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03150667

  80. Primary completion Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan Registry record

    Expected 2019-04-30; that period ended on 2019-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03231982

  81. Study completion Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy Registry record

    Expected 2019-04-30; that period ended on 2019-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03262363

  82. Study completion Remote Ischemic Conditioning Using the autoRIC Registry record

    Expected 2019-04; that period ended on 2019-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03318575

  83. Primary completion Remote Ischemic Conditioning Using the autoRIC Registry record

    Expected 2019-04; that period ended on 2019-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03318575

  84. Study completion Evaluation of Nail Fold Microcirculation in CKD Registry record

    Expected 2019-04-30; that period ended on 2019-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03682952

  85. Primary completion Evaluation of Nail Fold Microcirculation in CKD Registry record

    Expected 2019-04-30; that period ended on 2019-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03682952

  86. Study start Heart Monitoring Device After Acute Myocardium Infarction Registry record

    Expected 2019-05-01; that period ended on 2019-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03494751

  87. Study completion An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes Registry record

    Expected 2019-05-10; that period ended on 2019-05-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03216564

  88. Primary completion An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes Registry record

    Expected 2019-05-10; that period ended on 2019-05-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03216564

  89. Primary completion Effect of External Counter Pulsation on Coronary Artery Disease Registry record

    Expected 2019-05-28; that period ended on 2019-05-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03075124

  90. Study completion Performance of the CARDIOGARD Cannula Registry record

    Expected 2019-05; that period ended on 2019-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02764645

  91. Study completion A Randomized Comparison of Clinical Outcomes Between Everolimus-eluting Bioresorbable Vascular Scaffold Versus Everolimus-eluting Metallic Stent in Long Coronary Lesions Registry record

    Expected 2019-05; that period ended on 2019-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02796157

  92. Primary completion A Randomized Comparison of Clinical Outcomes Between Everolimus-eluting Bioresorbable Vascular Scaffold Versus Everolimus-eluting Metallic Stent in Long Coronary Lesions Registry record

    Expected 2019-05; that period ended on 2019-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02796157

  93. Study completion New Covered Stent (Willis) for the Endovascular Reconstruction of Intracranial Vessel Wall Defects Registry Registry record

    Expected 2019-05; that period ended on 2019-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02820779

  94. Primary completion New Covered Stent (Willis) for the Endovascular Reconstruction of Intracranial Vessel Wall Defects Registry Registry record

    Expected 2019-05; that period ended on 2019-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02820779

  95. Study completion A Study on the Efficacy and Gut Microbiota of Berberine and Probiotics in Patients With Newly Diagnosed Type 2 Diabetes Registry record

    Expected 2019-05; that period ended on 2019-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02861261

  96. Study completion Effect of Preoperative Aspirin in Patients Undergoing Off-pump Coronary Artery Bypass Grafting Registry record

    Expected 2019-05; that period ended on 2019-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03049085

  97. Primary completion Effect of External Counter Pulsation on Ischemic Stroke Registry record

    Expected 2019-05-31; that period ended on 2019-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03075137

  98. Study completion Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan Registry record

    Expected 2019-05-31; that period ended on 2019-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03231982

  99. Primary completion Guiding Hypertension Management Using Different Blood Pressure Monitoring Strategies Registry record

    Expected 2019-06-01; that period ended on 2019-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03578848

  100. Study start Trial of Oral Melatonin in Elevated Blood Pressure Registry record

    Expected 2019-06-01; that period ended on 2019-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03764020